urmila
WAVE trial AVG cohort also benefits at six-months with Wrapsody
Newly released six-month results from single-arm arteriovenous graft (AVG) cohort in the WAVE (Wrapsody arteriovenous access efficacy) trial showed target lesion and access circuit...
Reliability, ease-of-use and availability have made Skater™ drainage catheters a go-to...
This advertorial is sponsored by Argon Medical Devices.
Placing a drain is an important, quotidian, “bread and butter” procedure that often has a tremendous impact...
The WavelinQ™ EndoAVF System takes an innovative approach in creating endovascular...
This advertorial is ONLY available to watch in selected countries and geographies
This advertorial, sponsored by BD, is intended for readers in the EMEA...
Interventional News Issue 83—September 2021 US Edition
Issue 83 Highlights
CAVA RCT delivers powerful evidence supporting use of PORTs to supply systemic
chemotherapy
Wesley hospital becomes first in Australia to achieve IASIOS...
Interventional News Issue 83—September 2021 Edition
Interventional News 83 Highlights:
CAVA RCT delivers powerful evidence supporting use of PORTs to supply systemic
chemotherapy
Wesley hospital becomes first in Australia to achieve...
Guidelines will boost interventional oncology research
The development of new research guidelines for interventional oncology that standardise treatment outcomes and the reporting of data represents a major step forward for...
Global FACT trial reports significant superficial arm vein dilation with FA-1...
Fist Assist Devices has just announced completion of the FACT trial, which evaluated the use of an intermittent pneumatic compression device, model FA-1, to...
Latest meta-analysis on paclitaxel in peripheral arterial disease provokes mixed reception
“There appears to be heightened risk of major amputation after use of paclitaxel-coated balloons in the peripheral arteries,” findings from a systematic review...
CAVA RCT delivers powerful evidence supporting use of PORTs to supply...
For most patients receiving systemic anticancer treatment (SACT), totally implanted ports (PORTs) are more effective and safer than both Hickman-type tunnelled catheters (Hickman) and...
Virtual ACC: Renal denervation bests sham control to safely lower blood...
Three months after undergoing renal denervation, patients with untreated high blood pressure had statistically significant reductions in average blood pressure over 24 hours compared...
New meta-analysis finds “no observed difference” in mortality between paclitaxel and...
February 2020 brings another paclitaxel device meta-analysis of randomised controlled trials in chronic limb-threatening ischaemia (CLTI) patients. Krystal Dinh (Westmead Hospital, Sydney, Australia) et...
LINC 2020: One year IN.PACT AV results show sustained patency benefit...
NOTE: This video is ONLY available to watch in selected countries and geographies
The one-year IN.PACT AV trial results, first presented at LINC 2020 (28–31 January, Leipzig,...
High-grade evidence supports use of APERTO DCB in vascular access stenosis
Jos van den Berg (Lugano, Switzerland) tells Interventional News at CIRSE 2019 that the results of the APERTO AVF China trial provide strong evidence of the benefits of...
OUTBACK™ Elite Re-entry catheter highly effective at saving limbs in extreme...
Lorenzo Patrone (London, UK) shares with Blearning at CIRSE 2019 (7–11 September, Barcelona, Spain) the benefits of using the OUTBACK™ Elite Re-entry Catheter (Cordis,...
CIRSE 2019: Hear the latest from clinical trials comparing paclitaxel technologies...
NOTE: ONLY intended for healthcare professionals outside of the USA and France.
Zoom in on a tête-à-tete between Marianne Brodmann (Graz, Austria) and Giovanni Torsello...
Experts discuss latest results from EFFPAC and TINTIN trials presented at...
NOTE: ONLY intended for healthcare professionals outside of the USA.
Ulf Teichgräber (Jena, Germany) and Koen Deloose (Dendermonde, Belgium) discuss the 24-month results of the...
Learn more about the 24-month results of the Venovo Venous Stent...
Michael Dake (Tucson, Arizona) presented the two-year data from the VERNACULAR trial at CIRSE 2019 on 8 September in Barcelona, Spain.
Dake said: “The 24-month...
ET 2019: New microcatheters could help reduce the “everyday challenge” of...
Irene Bargellini (Pisa, Italy) tells BLearning IR at the first Embolotherapy conference (ET; 26–29 June, Valencia, Spain) that non-target embolization is a frequently under-diagnosed,...
Webinar: Safety of paclitaxel devices – what does the evidence say?
Jos van den Berg (Lugano, Switzerland), Antonio Micari (Bergamo, Italy) and Marianne Brodmann (Graz, Austria) sit down after a specially convened US FDA panel...
Road “wide open” for Osteocool radiofrequency ablation in patients with painful...
Jason Levy (Atlanta, USA) and Sandeep Bagla (Virginia, USA) talk to Interventional News about preliminary results from the ongoing OPuS One study. The OPuS...
Highlights from the CX 2019 session, Paclitaxel: the last word
Watch the video roundup from the CX2019 Highlight Session, Paclitaxel: The last word.
Filmed onsite at the Charing Cross Symposium (15–18 April 2019, London, UK).
Endovascular options gain ground in creation of haemodialysis lifelines
Until recently, creation, maintenance and restoration of vascular access function was entirely performed by open surgical methods. However, it is becoming apparent that endovascular...
Hear the latest thoughts on paclitaxel from global experts: Their current...
Following the latest information presented at the Charing Cross (CX) International Symposium related to the meta-analysis of paclitaxel-coated devices (Katsanos et al), hear from a...
CX 2019: Evidence supports safety of paclitaxel-coated devices
At the Charing Cross International Symposium, Gary Ansel (Columbus, Ohio) moderates a global panel that includes Thomas Albrecht (Berlin, Germany), Peter Schneider (San Francisco,...
Cook leads the way to data transparency with release of long-term...
There were calls for greater transparency and sharing of the available randomised controlled trial data of paclitaxel-coated devices at the CX 2019 Highlight Session, Paclitaxel:...
Sirolimus has “a much wider” safety window and shows fewer local...
Paclitaxel kills the cells in the artery wall; sirolimus simply stuns them. So says Peter Gaines (Sheffield, UK) at VLF 2019 while commenting on...
VLF 2019: Real world data provide glimpse into peripheral drug-eluting devices...
Eric Secemsky (Boston, USA) takes Interventional News through the main highlights of his recently published analyses of a US Medicare claims dataset that examined...
CRT 2019: Early feasibility data from alcohol-mediated renal denervation “seems very...
The renal denervation bubble collapsed due to a single trial—SYMPLICITY HTN-3, but this trial’s findings went against the grain, Horst Sievert (Frankfurt, Germany) tells Interventional...
Together, IO and RO can increase the scope of local tumour...
Bringing interventional oncology (IO) and radiation oncology (RO) closer together would yield more than important logistical gains for IO; it would open up a...
Customising therapy in femoropopliteal revascularisation
Gary Ansel (Columbus, USA) tells Vascular News at VEITHSymposium 2018 about how drug-based therapies have become a mainstay in femoropopliteal revascularisation and how interventionalists...
VIVA 2018 focuses on the critical issues in vascular medicine
In the arterial space, VIVA 2018 focused on the fact that there is an increasing awareness of limb threatening ischaemia coupled with an increase...
How does the novel Temporary Spur device work to “guarantee” drug...
Jihad Mustapha (Grand Rapids, USA) explains how the Temporary Spur stent system (Reflow), which is a spiked self-expanding stent is intended for use in...
Comparing and contrasting surgically-created AVFs with those made by endovascular means
Nicholas Inston (Birmingham, UK) tells Vascular News at LINC 2019 about the exciting field of percutaneous arteriovenous fistula (AVF) creation, the main devices and...
Thrombus dissolution with EKOS™ Acoustic Pulse Thrombolysis™ in everyday clinical practice
At the EKOS symposium at LINC 2019, Nils Kucher (Zurich, Switzerland), Houman Jalaie (Aachen, Germany) and Mert Dumantepe (Istanbul, Turkey) share their experiences in...
ULTRASCORE scoring helps obtain luminal gain at low inflation pressure before...
Dierk Scheinert (Leipzig, Germany) talks to Vascular News at LINC 2019 about the importance of vessel preparation with adjunctive therapies such as the use...
New data release at LINC 2019 reinforces safety profile of low-dose...
Sean Lyden (Cleveland, USA) and Fabrizio Fanelli (Rome, Italy) discuss the safety and future of drug-coated balloons (DCB) in light of the latest pooled...
Patient-level analysis shows no correlation between paclitaxel and mortality—reactions from LINC
Renowned experts expressed confidence in the continued use of paclitaxel-coated devices after independent patient-level data presented at LINC 2019 did not show correlation between...
IN.PACT independent patient-level meta-analysis shows no correlation between paclitaxel exposure and...
A renowned panel, moderated by Dierk Scheinert (Leipzig, Germany), comprising Peter Schneider (Honolulu, USA), John Laird (St Helena, USA) and Thomas Zeller (Bad Krozingen,...
New developments in treatment of deep venous thrombosis
An analysis ATTRACT has just been published in the journal, Circulation in which the authors examine the effect of pharmacomechanical catheter-directed therapy (PCDT) in ATTRACT...
SWEDEPAD 1 and SWEDEPAD 2 trials halt inclusion after Katsanos et...
Interventional News has learned that inclusion into the SWEDEPAD studies, that are examining benefits of drug-eluting technology for peripheral arterial disease patients, has been...
Meta-analysis finds a higher risk of death in the long term...
Konstantinos Katsanos (Patras, Greece) tells Interventional News about new data from a meta-analysis that has been published in the Journal of the American Heart...
Meta-analysis finds a higher risk of death in the long term...
New data, just published in the Journal of the American Heart Association (JAHA), suggest that there is an increased risk of death at two...
A call to arms: Recruit physicians with endovascular skills to treat...
“There are simply not enough trained specialists to treat stroke patients in the US. We need to recruit physicians with endovascular skills—interventional cardiologists,...
PCSK9 inhibitors, rivaroxaban and a diabetes drug are major milestones in...
Michael Jaff (Newton, USA) outlines the major recent developments in best medical therapy that will impact the treatment of peripheral arterial disease (PAD) at...
Appropriate patient and device selection and multidisciplinary team discussion make for...
Raman Uberoi (Oxford, UK) tells Interventional News at CIRSE 2018 in Lisbon, Portugal, that offering any treatment for abdominal aortic aneurysms, be it endovascular...
Consider intravascular lithotripsy when treating calcified femoropopliteal arteries
Treating severely calcified arteries by endovascular means is still a challenge, although atherectomy, stents and lithotripsy are all techniques that are employed. Lithotripsy (also...
Individual evaluation of each patient, and each aorta, is key to...
Individual evaluation of each patient, and each aorta, is key to durable repair
“The instructions for use (IFU) are not a clinical guideline, so trainees...
Diversity in IR is crucial to harnessing the best ideas and...
Daniel Sze (Stanford, USA) tells Interventional News that the focus on diversity is not just about social justice. “It is really about bringing the many good...
Balt announces receiving CE mark for Magic Glue, a next generation...
Balt International has announced receiving the CE mark for Magic Glue, its next generation of cyanoacrylate liquid embolic agent. Magic Glue is indicated for...
Lutonix Global AV Registry: DCB use prolongs time to reintervention in...
Tobias Steinke (Dusseldorf, Germany) reported on the Lutonix Global arteriovenous (AV) Registry at CIRSE 2018 in Lisbon, Portugal. Lutonix Global AV Registry data add to...
Use of snuffbox technique for distal radial access expands due to...
Darren Klass (Vancouver, Canada) tells Interventional News that social media is helping spread the word about the back hand approach for distal radial access....
Addressing concerns about radiation is key to attracting more women into...
Sneak preview: Anna Maria Belli (London, UK; right in video), who was awarded the CIRSE Gold Medal at the 2018 meeting in Lisbon, Portugal,...
Using the transradial approach in visceral embolization has huge benefits for...
Christoph Binkert (Kantonsspital, Winterthur, Switzerland) tells Interventional News at CIRSE 2018 in Lisbon, Portugal, that the transradial approach is rapidly gaining momentum in Europe...
Embolization for trauma should be performed only by highly trained and...
Robert Morgan, St George’s University Hospitals NHS Foundation Trust, London, UK, discusses the role of interventional radiologists (IRs) in trauma embolization; and whether other...
IMPERIAL trial shows Eluvia outperforms Zilver PTX at one year
Andrew Holden (Auckland, News Zealand) interviews Stefan Mueller-Huelsbeck (Flensburg, Germany) to distil the key findings of the IMPERIAL trial one-year data that were presented...
Vicki Marx outlines her goals as SIR President
M Victoria Marx, an interventional radiologist at Keck Medicine of USC, Los Angeles, USA, has been appointed president of the Society of Interventional Radiology...
BTG acquires Novate Medical
BTG has announced it has acquired Novate Medical, a medical device company focused on the prevention of pulmonary embolism in patients at high risk...
US IDE trial finds embolization “safe and efficacious” for benign prostatic...
A prospective US FDA-approved investigational device exemption (IDE) study has demonstrated significant improvement in lower urinary tract symptoms secondary to benign prostatic hyperplasia and...
First-ever CE mark of a bioresorbable scaffold for below-the-knee PAD
Reva Medical, a company developing bioresorbable polymer technologies for vascular applications, has announced that its Motiv bioresorbable scaffold is the first drug-eluting bioresorbable scaffold...
New augmented reality system lets IRs “literally see through the patient”
European Radiology Experimental has recently published a study on a new augmented reality system that is able to accurately guide interventional oncology procedures. A three-step...
ABK Biomedical appoints Michael J Mangano as president and CEO
ABK Biomedical, a company dedicated to the research, development and commercialisation of innovative embolic therapies, has announced the appointment of Michael J Mangano as...
US FDA grants Breakthrough Therapy Designation for combination immunotherapy in HCC...
Roche has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for Tecentriq (atezolizumab) in combination with Avastin (bevacizumab)...
Merit Medical named exclusive distributor of Q50 Plus
Merit Medical Systems has been named the exclusive global distributor of the Q50 Plus Stent Graft Balloon Catheter (QXMédical). The Q50 Plus is used...
BD acquires TVA Medical, makers of everlinQ endoAVF System
BD (Becton, Dickinson and Company) announced it has completed the acquisition of TVA Medical, a company that develops minimally invasive vascular access solutions...
FDA updates advisory letter on device-related type III endoleak risks
An update to last year’s FDA letter, expressing concern over risk of type III endoleaks in relation to endovascular graft systems, now states that...
Impede embolization plug gets US FDA clearance
Shape Memory Medical announced it has received 510(k) clearance from the US Food and Drug Administration (FDA) for the Impede embolization plug. The device...
Terumo gets CE mark for Kanshas drug-coated balloon catheter for lower...
Terumo has announced receiving the CE mark for its Kanshas drug-coated balloon catheter used in the treatment of lower extremity peripheral arterial disease.
With...
Prostatic artery embolization improves BPH symptoms nearly as much as TURP...
A randomised, open label trial that was published in the BMJ on 19 June 2018 suggests that the improvement in lower urinary tract symptoms...
Sirtex prefers US$1.4 billion CDH-CGP bid to Varian’s acquisition offer
Sirtex has announced entering into a binding scheme implementation deed with CDH Genetech (CDH) and China Grand Pharmaceuticals and Healthcare Holdings Limited (CGP). It...
Medtronic receives US FDA clearance for 200mm and 250mm IN.PACT Admiral...
Medtronic has announced that it has received US FDA approval for 200mm and 250mm lengths of the IN.PACT Admiral drug-coated balloon (DCB) to treat...
Archimedes biodegradable biliary and pancreatic stent gets CE mark
Amg International, a wholly owned subsidiary of Q3 Medical Devices, announced that it has received CE mark approval for their novel biodegradable biliary and pancreatic...
Gas embolotherapy generated microbubbles could provide vehicle for cutting off blood...
Recently, scientists have explored another version of embolization, called gas embolotherapy. During this process, the blood supply of cancerous tumours is cut off using...
Artificial intelligence will support clinical decision making in interventional oncology
Aaron Abajian and Julius Chapiro, New Haven, USA, write about results from an early experiment in applying artificial intelligence (AI) and machine learning as a...
Immersive nature of virtual reality will “herald a sea change” in...
The Society of Interventional Radiology (SIR) debuted the first-ever virtual reality 360 (VR360) training video showcasing an endovascular transjugular intrahepatic portosystemic shunt (TIPS) procedure...
Embozene microspheres are now indicated for prostate artery embolization
Boston Scientific showed at the Global Embolization Cancer Symposium and Technologies (GEST US; 17–19 May, Miami Beach, USA) meeting that the US Food and...
New data demonstrate clinical experience with LifePearl microspheres in over 300...
Transarterial chemoembolization (TACE) using LifePearl (Terumo) drug-eluting embolic agents in the treatment of hepatocellular carcinoma has just been published.
International survey reveals high variability in TACE technique
Transarterial chemoembolization (TACE) is a mainstay of locoregional treatment for hepatocellular carcinoma (HCC) in the intermediate stage. “The technique for this procedure, however, continues...
VERTOS IV raises doubts about vertebroplasty
Percutaneous vertebroplasty does not result in statistically significant greater pain relief than a sham procedure, reports a study detailing the results of the VERTOS...
New renal denervation data show significant blood pressure reduction in patients...
Late-breaking SPYRAL HTN-ON MED study at EuroPCR indicates renal denervation lowers blood pressure in hypertensive patients in presence of blood pressure medication.
Medtronic has announced...
New CMS reimbursement code “severely underpays” for drug-coated balloons
Drug-coated balloon (DCB) angioplasty devices have been categorised by the US Centers for Medicare and Medicaid Services (CMS) into the same billing code as...
Addressing the data deficit for drug-coated balloon use in dialysis access
The first 24-month data from the LUTONIX AV investigational device exemption trial were presented at the Charing Cross Symposium in April. These interim data...
Vascutek and Bolton Medical merge to become Terumo Aortic
Vascutek and Bolton Medical, subsidiaries of Terumo Corporation of Japan, have combined into a single, integrated business, Terumo Aortic.
IN.PACT Admiral DCB receives FDA approval for long SFA lesions
Medtronic has announced that it has received US Food and Drug Administration (FDA) approval for the IN.PACT Admiral drug-coated balloon (DCB) to treat long superficial...
UK NICE’s recommendation of prostatic artery embolization is a “huge development”
https://www.youtube.com/watch?v=QH9H-hwdb6o&feature=youtu.be
Francesco Carnevale (São Paulo, Brazil) speaks on the growing acceptance for prostatic artery embolization. The national regulatory bodies in Brazil and the UK recommending...
CX 2018: Ulf Teichgräber discusses EffPAC trial 12-month results
Ulf Teichgräber, Jena, Germany, discusses the EffPAC trial 12-month results which were presented for the first time at CX 2018
The UK’s NICE recommends prostate artery embolization for selected men with...
The National Institute for Health and Care Excellence (NICE), which provides national guidance and advice to improve health and social care, has decided that...
Radiation segmentectomy offers new treatment option for liver cancer
Radiation segmentectomy is a minimally invasive option that uses the radioisotope yttrium-90 (Y90) to destroy tumours. One-, three-, and five-year overall survival probability was 100%, 82% and 75% in patients with a baseline tumour size of 3cm or less.
Landmark EVRA trial provides first Level 1 evidence for early endovenous...
The first full results of the Early Venous Reflux Ablation (EVRA) ulcer study were presented at the Charing Cross Symposium (24–27 April, London, UK)....
Guerbet acquires Occlugel and new microsphere technology for initial €3 million...
Guerbet has announced that it has signed an agreement to acquire a laboratory-stage technology developed by Occlugel, a French company specialised in the research...
Vascutek and Bolton Medical merge to become Terumo Aortic
Vascutek and Bolton Medical, subsidiaries of Terumo Corporation of Japan, have combined into a single, integrated business, Terumo Aortic.
Forge Medical announces commercialisation agreement with Lokai Medical
Forge Medical, a US developer of solutions for transradial and transpedal haemostasis and manufacturer of the VasoStat haemostasis device, announced today that the company...
Medtronic expands IO focus with US launch of OptiSphere embolization spheres
Medtronic announced the US launch of OptiSphere embolization spheres, a resorbable embolic platform designed for embolization of hypervascular tumours.
OptiSphere offers patients an alternative treatment...
SIRT fails to extend survival in the SORAMIC study palliative cohort
The SORAMIC study, presented at The International Liver Congress, shows that the addition of selective internal radiation therapy (SIRT) to sorafenib in patients with...
Guerbet announces Lausanne partnership to evaluate immunogenic potential of cTACE
Guerbet has announced a partnership with the Department of Radiodiagnosis and Interventional Radiology of Lausanne's University Hospital (CHUV) and the Lausanne Center for Experimental...
Medical societies issue revised, patient-centred measures for stroke interventions
Society of Interventional Radiology (SIR) publishes guidelines on clinical practice of intra-arterial stroke revascularisation
Revised guidelines for the non-surgical, image-guided interventional treatment of acute ischaemic...
New products showcased at SIR 2018
There were several devices in the New Product Showcase at the Society of Interventional Radiology's Annual Scientific Meeting in Los Angeles, USA. Among these...
Society of Interventional Radiology names M Victoria Marx president for 2018–19
M Victoria Marx, an interventional radiologist at Keck Medicine of USC, Los Angeles, USA, has been appointed president of the Society of Interventional Radiology...
Cryovagotomy may help ignite weight loss
Cryoablation of the posterior vagal trunk, the nerve carrying hunger signals to the brain, may help patients with mild-to-moderate obesity lose weight, according to...
Less expensive and more realistic 3D models of blood vessels improve...
A relatively inexpensive 3D-printed model of a patient’s blood vessels is as effective as current commercially available models for training medical students in interventional...
Targeted immunotherapy treatment shows promise for treating for advanced liver cancer
Advanced stage liver tumours may be safely treated through image-guided injections of an immunotherapy approved for melanoma, according to phase 1 data presented at...
Early data show arterial embolization reduces knee pain and disability from...
Geniculate artery embolization could improve quality of life for patients with knee pain due to osteoarthritis, according to new research presented at the Society...
Interactive virtual reality enhances physicians’ treatment planning of complex conditions
Virtual reality (VR) provides interventional radiologists with a 360-degree view of internal anatomy to enhance procedure planning.
Interactive VR brings medical images to life on...
Lack of diversity “one of the biggest” challenges facing IR
Fostering a diverse interventional radiology (IR) workforce is difficult, but vital, because heterogeneous groups can be more innovative, be better at complex problem-solving, achieve...
First patients enrolled in Wing-IT investigational device exemption clinical trial
Reflow Medical announced that the first patients have been enrolled in a prospective, multicentre, non-randomised study intended to evaluate the ability of the Reflow...
Hospital brings emergency REBOA procedure training to trauma US specialists
Grady Memorial Hospital, the first in Georgia, USA, to perform resuscitative endovascular balloon occlusion of the aorta (REBOA), will soon offer trauma specialists around...
Siemens Healthineers launches Acuson Juniper ultrasound system at ECR
Acuson Juniper is a new ultrasound system with advanced applications and imaging performance while featuring a lightweight, ergonomic design and complete manoeuvrability for use...
ECR 2018: Will immunotherapy revolutionise cancer care?
Evasion of the immune system is an important mechanism in the development and progression of cancers. Cancer immunotherapies are a promising class of therapeutic...
Artificial intelligence and big data in medical imaging will dramatically change...
The analysis of big data with artificial intelligence (AI) techniques will have an enormous impact on disease prevention, cure and care. By 2030, it...
Oxygen monitoring predicts wound healing in critical limb ischaemia patients after...
Preliminary findings from an initial study with 25 patients have shown that measuring the changes in oxygen concentration at baseline, during, and after endovascular...
First patient enrolled in CIREL, a Europe-wide observational study on TACE...
The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) announced that the first patient has been enrolled in CIREL (CIRSE registry for LifePearl microspheres),...
Mark Breedlove and DJ Sirota to lead new Cook Medical business...
Cook Medical has announced the leaders of its two new business divisions. Mark Breedlove has been named vice president of Cook’s Vascular division and...
Terumo to acquire large bore vascular closure device to expand its...
Terumo Corporation has announced that it has entered into an agreement to acquire assets related to the large bore vascular closure device, Xpro System,...
Clinical capabilities of Infinix-i 4D CT showcased at ECR 2018
Healthcare centres around Europe are realising a new realm of clinical efficiency with the Infinix-i 4D CT system, which seamlessly integrates interventional radiology and...
First data from AVeVA suggest Covera stent “safe and effective” at...
Early data from the prospective multicentre AVeVA study that employed a covered stent (Covera; Bard, now BD) to treat stenoses at the venous anastomosis...
Virtual reality enters the IR suite
Whether you are chasing Pikachu in the park or planning an IR procedure, virtual reality is increasingly "part of life" and has huge opportunities...
US FDA clears CorPath GRX system for use in peripheral vascular...
Corindus has announced receiving 510(k) clearance from the US Food and Drug Administration (FDA) for use of the CorPath GRX system in peripheral vascular...
Cook Medical announces major realignment of its business
Cook Medical has announced key changes that simplify its organisational structure to better support customers.
These changes realign the current sales, marketing, research and...
New liquid embolic agents, Squidperi 34 and 34LD, get CE mark
Balt International announced that it has received CE mark for the Squidperi 34 and 34LD liquid embolic agents.
Squidperi is a non-adhesive liquid embolic agent...
MagForce gets US FDA nod to begin clinical trial evaluating focal...
The US FDA’s granting of an investigational device exemption (IDE) allows MagForce to conduct a pivotal clinical evaluating the company’s NanoTherm therapy for intermediate...
Latest data on Lutonix and IN.PACT drug-coated balloons in AV access...
There in an increasing physician interest in exploring the role of drug-coated balloons in arteriovenous (AV) access. At the Leipzig Interventional Course (LINC; 30...
One-year OPTALYSE PE results reinforce safety and efficacy of shorter, lower...
The study results with the Ekos system (BTG) were presented at the International Society on Endovascular Therapy (ISET; 3–7 February 2018, Florida, USA).
The findings...
First data from head-to-head comparison of Ranger and IN.PACT drug-coated balloons...
Early data from the first randomised controlled trial to compare two drug-coated balloons (DCBs) suggest that the primary patency obtained with the Ranger DCB...
Meta-analysis shows positive experience for patients who received an endovascular arteriovenous...
An international meta-analysis of clinical experience in patients who received an endovascular arteriovenous fistula (endoAVF) for haemodialysis access was presented at Leipzig Interventional Course...
LimFlow completes enrolment in US feasibility study
LimFlow has announced completion of enrolment of the original 10-patient cohort in the US feasibility study of the LimFlow percutaneous deep vein arterialisation system....
New proprietary gel-coated biocompatible embolic, GPX, presented at LINC
Two scientific abstracts of a new vascular embolic device, GPX (Fluidx Medical Technology) were presented this week at the 2018 Leipzig Interventional Congress (LINC;...
Bentley launches BeGraft Plus stent graft in Europe
Bentley has launched BeGraft Plus, a covered balloon expandable stent indicated for restoring and improving the patency and treatment of aneurysms, acute perforations and...
One-year MIMICS-2 results show BioMimics 3D stent results in nearly 90%...
Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS-2, a prospective, single arm, multicentre clinical study to evaluate the safety...
Varian signs agreement to acquire Sirtex
Varian Medical has announced it has signed an agreement to acquire all the outstanding shares of Sirtex Medical for A$28 per share in cash....
LINC 2018 data highlight IN.PACT Admiral as safe and effective treatment...
Medtronic added to its robust body of clinical evidence supporting the IN.PACT Admiral drug-coated balloon with new presentations that demonstrated durable and consistent clinical...
New ischaemic stroke guidelines widen mechanical thrombectomy window to 24 hours...
The American Heart Association and American Stroke Association released updated ischaemic stroke guidelines that were published in Stroke, and released during the International Stroke...
“Aspiration first” approach with Penumbra system demonstrates favourable outcomes for acute...
Penumbra announced results of the company-sponsored PROMISE study, demonstrating real-world safety and efficacy of the Penumbra system with ACE 68 and ACE64 reperfusion catheters...
ENCHANT will evaluate ChEVAR technique with Endurant II/IIs stent graft system
The post-market, non-interventional, multicentre, non-randomised, single-arm study will enroll approximately 150 patients across 25 sites in Europe and Russia, and will evaluate the safety...
Terumo Europe NV announces approval of LifePearl as a Class III...
This approval also expands the number of chemotherapeutic drugs that can be loaded onto LifePearl to include idarubicin and epirubicin, a press release from...
New UK guidance on training IR to speed up roll out...
Emergency mechanical thrombectomy dramatically increases a stroke patient’s chance of a full recovery. The UK does not have enough skilled doctors to provide the procedure....
Surefire Medical appoints Mary T Szela CEO and president
Szela brings nearly 30 years of progressive leadership experience to Surefire building global billion-dollar brands, advancing pipeline products in the biotechnology, medical products, and...
Liquid biopsy test shows promise for detecting early-stage colorectal cancer
A new study has found that a test that identifies circulating tumour cells (CTCs) present in the bloodstream can detect colorectal cancer at an...
Surmodics gets US FDA 510(K) clearance for Telemark support microcatheter
Surmodics has announced receiving US FDA 510(k) clearance for its Telemark 0.014” coronary and peripheral support microcatheter. The company is making this product available...
BD announces completion of enrolment in Lutonix 014 DCB below-the-knee trial
Enrolment is complete in the Lutonix below-the-knee trial with BD planning to submit a pre-market approval application to the US Food and Drug Administration...
New Vascular Ultrasound Registry launched, will initial focus on carotid artery...
The registry will combine noninvasive, vascular ultrasound testing data with vascular treatment and outcomes data, making it possible to analyse the relationships between diagnosis...
When to consider TEVAR in uncomplicated Type B aortic dissection
A new study suggests thoracic endovascular aortic repair (TEVAR) may be appropriate in uncomplicated Type B aortic dissection (TBAD) based on several anatomic criteria...
Medtronic gets US FDA clearance for Riptide aspiration system
The Riptide aspiration system is intended for use in the revascularisation of patients with acute ischaemic stroke secondary to intracranial large vessel occlusive disease...
ECR 2018 to spotlight artificial intelligence, debut special IR programme
The upcoming annual meeting of the European Society of Radiology (ESR; 28 February – March 4, 2018, in Vienna, Austria) has adopted the motto...
Viz.ai announces CE mark for first artificial intelligence powered direct-to-intervention system
Viz.ai has announced the CE mark of its direct-to-intervention system, ContaCT, a novel approach to stroke care that automatically analyses brain CTs and notifies...
Guerbet acquires IR microcatheter maker Accurate Medical
Guerbet has announced that it has entered into an agreement under which it will acquire Israeli company Accurate Medical, which specialises in the development...
Vascular plugs score over platinum coils on radiation dose in pelvic...
A prospective, randomised single-centre study that set out to compare the safety and efficacy of vascular plugs and fibred platinum coils for embolization in...
Toshiba Medical is now Canon Medical
Canon and Canon Medical Systems Corporation have announced the official name change of Toshiba Medical, which was acquired in 2016, to Canon Medical Systems...
Penumbra announces formation of virtual reality joint venture with Sixense Enterprises
Penumbra has announced that it has entered into a joint venture called MVI Health, for the purpose of exploring healthcare applications of virtual reality...
First patient enrolled in investigational study of Gore Excluder conformable endoprosthesis...
W L Gore and Associates has announced the first implant of the Gore Excluder conformable abdominal aortic aneurysm endoprosthesis in the USA. The procedure...
Medtech organisations release joint statement on phase-out of direct sponsorships
The Global Medtech industry is moving together to enhance compliance practices across Europe, China, the Middle East, North Africa and Asia-Pacific, announces a statement...
Teleflex gets new CEO
Teleflex has announced that it has completed its previously announced senior leadership transition with Liam Kelly succeeding Benson Smith as president and chief executive...
Multicentre UK registry results highlight embolization strengths and importance of physician...
First results from the UK-ROPE multicentre registry reveal that prostatic artery embolization is highly effective in reducing lower urinary tract symptoms in men with benign prostatic obstruction.
XableCath gets US FDA clearance for broadly effective catheter aimed at...
XableCath has announced its XableCath blunt tip support catheter has received clearance from the US FDA. The blunt tip catheter facilitates true lumen passage...
Northwestern University adopts radioembolization with TheraSphere as first-line treatment for HCC
BTG has announced that following positive results of its 15-year experience between 2003 and 2017 with TheraSphere, Northwestern University, Illinois, USA, has adopted Y-90...
Philips acquires VitalHealth
Royal Philips has announced that it has acquired VitalHealth, a provider of cloud-based population health management solutions for the delivery of personalised care outside of...
More than one in six patients with PAD who undergo revascularisation...
A study of nearly 62,000 hospitalisations nationwide in the USA has found that more than one in six patients with peripheral arterial disease (PAD)...
InspireMD announces expansion of its distribution network for CGuard EPS in...
InspireMD has announced it has signed Diverse Devices as its exclusive distributor for Australia and New Zealand, and has signed Do Gia Production...
Image-guided pulsed radiofrequency provides relief from low back pain
The majority of patients were pain free after receiving a new image-guided pulsed radiofrequency treatment for low back pain and sciatica, according to a...
Study finds no evidence that gadolinium causes neurologic harm
There is no evidence that accumulation in the brain of the element gadolinium speeds cognitive decline, according to a new study presented at the...
MIM software receives US FDA 510(k) clearance for post-treatment dosimetry of...
Dosimetry, within the context of selective internal radiation therapy (SIRT) using Y-90 microspheres, is typically understood to be the measurement and calculation of the...
Brave Dreams trial finds venous angioplasty “safe, but largely ineffective” for...
Paolo Zamboni, Ferrara, Italy, the proponent of the chronic cerebrospinal venous insufficiency (CCSVI) theory, and his colleagues have reported that the randomised, double-blinded, sham...
Positive 24-month TOBA results presented at VEITHsymposium
Intact Vascular has announced that positive single centre twenty-four month results from its TOBA (Tack optimised balloon angioplasty) clinical study were presented at VEITHsymposium...
Merit to acquire BD’s biopsy and drainage assets for US$100 million
Merit Medical has announced signing an asset purchase agreement with BD (Becton, Dickinson and company) to acquire certain assets which BD proposes to sell...
New study shows significant clinical workflow and staff experience benefits of...
Philips has announced the results of a comprehensive, independent, two-year study demonstrating the clinical workflow benefits of its next generation image-guided therapy platform, Azurion.
The...
Image-guided, minimally invasive medicine revolutionises emergency care
The Society of Interventional Radiology (SIR), in coordination with Member of the US House of Representatives (Rep.) from Utah's 4th district, Mia Love, hosted...
Initial experience suggests cryoablation effective in treatment of benign soft tissue...
“There is little experience with the use of cryoablation in children. Our aim was to evaluate the feasibility of cryoablation for benign soft tissue...
LIMBO-ATX trial studying Bullfrog device in critical limb ischaemia patients completes...
Mercator MedSystems has announced completion of enrolment in the company’s LIMBO-ATX (Lower-limb adventitial infusion of dexamethasone via Bullfrog to reduce occurrence of restenosis after...
Theoretical benefit with microwave ablation “does not translate into clinical benefit”...
A prospective randomised controlled study that compared outcomes between hepatocellular carcinoma patients who were treated by microwave ablation with those who were treated by...
US FDA clears first 7T magnetic resonance imaging device
The US Food and Drug Administration has cleared the first seven tesla (7T) magnetic resonance imaging (MRI) device, more than doubling the static magnetic...
First patient treated with vandetanib-eluting beads that are visible on CT...
Researchers from the University College London (UCL) Cancer Institute, London, UK, and BTG have begun the first clinical trial of an experimental treatment for...
Randomised trial finds prostatic artery embolization “a real treatment alternative” to...
Six-month results from a prospective, randomised, non-inferiority study presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE; 16–20 September, Copenhagen, Denmark) reveal...
Cook Medical’s inferior vena cava filters fare better than ALN’s in...
Gerard Goh, Radiology, The Alfred Hospital, Melbourne, Australia, reported results from a comparative study of inferior vena cava (IVC) filters at CIRSE 2017 that...
Discovery of healing molecule could reduce limb amputations for diabetes patients
Scientists have discovered new information about a molecule which is part of the body’s tissue repair system. This finding could help treat non-healing wounds...
BTG acquires Roxwood Medical
BTG today announces it has acquired Roxwood Medical, an innovative provider of advanced cardiovascular specialty catheters used in the treatment of patients with severe...
Teleflex completes acquisition of UroLift creator, NeoTract
Teleflex has announced the completion of its previously announced acquisition of NeoTract.
Founded in 2004, NeoTract is a privately-held medical device company that has developed...
iVascular initiates TINTIN Luminor trial
iVascular SLU has announced the initiation of the TINTIN trial, evaluating the combined therapy of Luminor drug-coated balloon (DCB) and iVolution self-expandable stent.
The TINTIN...
Vast majority of patients prefer radial access for embolization therapies in...
“While both radial and femoral accesses are safe and effective for transarterial liver embolization, it is clear that the patients prefer radial access,” said Marcelo Guimaraes, Charleston, USA, who was presenting on the...
CAVA trial to shed light on clinical and cost-effectiveness of routinely...
The world’s largest randomised trial comparing three central venous access devices—peripherally inserted central catheters (PICCs), Hickman-type devices and chest wall ports—should provide definitive results...
Eluvia paclitaxel-eluting stent shows long-term freedom from revascularisation at three years
Boston Scientific has announced the three-year results from the MAJESTIC trial for the Eluvia paclitaxel-eluting vascular stent system at the Cardiovascular and Interventional Radiological...
Terumo launches QuiremSpheres microspheres in Europe
Terumo has announced that it has launched QuiremSpheres microspheres in Europe on 18 September.
QuiremSpheres, the next generation of selective internal radiation therapy (SIRT) microspheres...
Luminor DCB shows high clinical effectiveness in six-month EffPAC data
The six-month results from the full clinical cohort of the EffPAC randomised study were presented in the drug-coated balloon (DCB) abstracts session at the...
Guerbet announces CE mark for Vectorio mixing and injection system for...
Guerbet has announced obtaining the CE mark for its conventional transarterial chemoembolization (cTACE) mixing and injection system, Vectorio.
Designed in collaboration with interventional radiologists worldwide,...
CIRSE launches new journal—CVIR Endovascular
Cardiovascular and Interventional Radiological Society of Europe (CIRSE) has announced the start of a new journal, CVIR Endovascular, which will be an offshoot of...
Mentice aims to reduce TACE procedure times and radiation exposure with...
Mentice has announced the release of a new simulation training software for transarterial chemoembolization (TACE). The new software was showcased at the 2017 CIRSE...
Could new study showing significant blood pressure reductions reignite interest in...
Medtronic has announced its intent to move forward with a new renal denervation pivotal trial following positive first results from a sham-controlled study in...
Bard gets US FDA premarket approval for Lutonix 035 DCB in...
Bard’s Lutonix 035 drug-coated balloon PTA catheter (DCB) has been granted premarket approval (PMA) by the US Food and Drug Administration (FDA) for a...
Women largely unaware of uterine fibroid embolization
American women are largely unaware of uterine fibroid embolization according to results from a new nationwide poll released by the Society of Interventional Radiology...
BTG and SIO expand Immuno-Oncology / Interventional Oncology grant programme
BTG and the Society of Interventional Oncology (SIO) have expanded their commitment to the Immuno-oncology /interventional oncology research grant programme, by announcing a second...
Siemens Healthineers receives CE mark for 7 Tesla scanner Magnetom Terra
Siemens Healthineers has received the CE mark for the 7 Tesla magnetic resonance (MR) scanner Magnetom Terra, making it the first-ever ultra-high-field MR scanner...
Philips completes acquisition of Spectranetics
Philips has announced that it has completed the acquisition of The Spectranetics Corporation, a US-based global leader in vascular intervention and lead management solutions....
Dexamethasone treatment prevents TACE side-effects in hepatocellular carcinoma patients
A randomised, double-blind, placebo-controlled trial evaluating the efficacy of prophylactic dexamethasone in preventing the most frequent adverse events of transcatheter arterial chemoembolization (TACE) in...
ASTER trial finds “no increased rate of revascularisation” with stent retriever...
The ASTER randomised clinical trial that examined the effect of endovascular contact aspiration vs. stent retriever on revascularisation in patients with acute ischaemic stroke...
Lutonix registry data confirm durability of drug-coated balloon treatment in superficial...
The 24-month results of the worldwide experience with Lutonix 035 drug-coated balloon (CR Bard/Beckton Dickenson) were published online in August in JACC: Cardiovascular Interventions....
Single and double needle ultrasound-guided irrigation have a place in treatment...
According to a new study published online in the journal Radiology, when ultrasound-guided percutaneous irrigation is performed to treat shoulder calcification, the choice of...
Same day Y-90 treatment could become paradigm of the future
While further refining where radioembolization should optimally lie in current treatment paradigms for the most common liver-confined or liver-dominant cancers is important, a honing...
New study uses cryoablation to target vagus nerve and obesity
A new study is underway at Emory Healthcare, Atlanta, USA, to evaluate the use of cryoablation to treat mild to moderate obesity.
The clinical trial,...
Gore Viatorr TIPS Endoprosthesis with Controlled Expansion may reduce portal hypertension...
The Gore Viatorr TIPS endoprosthesis with Controlled Expansion, a new device configuration developed by Gore, may reduce portal hypertension treatment complications, even when compared...
Johnson and Johnson announces new neurovascular business, Cerenovus
Johnson and Johnson Medical Devices Companies introduced Cerenovus, its new neurovascular business, at the Society of NeuroInterventional Surgery 14th Annual Meeting (SNIS; 24–28 July,...
Spectranetics announces FDA approval of Stellarex drug-coated balloon
Spectranetics has announced receipt of US Food and Drug Administration (FDA) premarket approval of the Stellarex drug-coated balloon (DCB), designed to restore and maintain...
SIR issues position statement encouraging paid parental leave
The Society of Interventional Radiology and its Women in Interventional Radiology section have issued a position statement to support interventional radiologists who choose to...
Update for CIRSE’s European IR Curriculum and Syllabus
The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) has announced the presentation of the second edition of the European Curriculum and Syllabus for...
Stephen Solomon assumes Society of Interventional Oncology presidency
The Society of Interventional Oncology (SIO) has announced new officers and a Board of Directors.
Stephen Solomon, chief of Interventional Radiology at Memorial Sloan Kettering...
Gore announces first TEVAR with Gore Tag conformable thoracic stent graft...
Gore has announced the first patient implant of conformable thoracic stent graft with Active Control System after receiving CE mark last month. The first...
Journal of Vascular and Interventional Radiology has growing impact on medicine
The Journal of Vascular and Interventional Radiology’s (JVIR’s) impact factor—one measure of a journal’s influence based on the number of article citations compared to...
BIOFLEX-1 pivotal trial results demonstrate safety and efficacy of Pulsar-18 stent...
Biotronik has announced that 12-month data from the BIOFLEX-I study have demonstrated the safety and efficacy of the company’s Pulsar-18 self-expanding stent for blocked...
Right-side survival data from SIRFLOX/FOXFIRE global studies presented at WCGIC
Sirtex has announced the presentation of the SIRFLOX/FOXFIRE Global right-side survival data in metastatic colorectal cancer at the 19th European Society for Medical Oncology...
Early data finds image-guided ablation “feasible and well tolerated” for oligometastatic...
A retrospective review of single-institution experience, published in July in the Journal of Vascular and Interventional Radiology (JVIR), suggests that percutaneous image-guided ablation is...
Radiofrequency ablation used to treat cancer pain for patients
Interventional radiologists at the Emory Johns Creek Hospitals (EJCH), Johns Creek, USA, are using radiofrequency ablation to reduce pain for cancer patients.
Radiofrequency ablation is...
Philips acquires CardioProlific
Royal Philips has announced the acquisition of CardioProlific Inc, a USA-based, privately-held company that is developing catheter-based thrombectomy approaches to treat peripheral vascular disease. Financial...
Augmenix announces first prostate cancer patients treated with SpaceOAR hydrogel in...
Augmenix, a medical technology company that develops, manufactures, and sells proprietary absorbable hydrogels that separate and protect organs at risk during radiotherapy and interventional...
Philips sets sights on Spectranetics, also acquires CardioProlific
Royal Philips and The Spectranetics Corporation announced that they have entered into a definitive merger agreement. Pursuant to the agreement, Philips will commence a...
Embosphere receives US FDA de novo classification for prostatic artery embolization
Merit Medical has announced that it has received 513(f)(2) (de novo) classification from the FDA to expand indication for its Embosphere microspheres. The indication...
Argon Medical formalises Medical Advisory Board
Argon Medical announced in June that it has formalised a Medical Advisory Board comprised of distinguished physicians from institutions across the USA who specialise...
WCIO session highlights the pick of recent interventional oncology research
A session at the World Conference on Interventional Oncology (WCIO; 8–11 June, Boston, USA), organised by the Society of Interventional Oncology (SIO), identified the...
ACCESS PTS study demonstrates Ekos’ efficacy in treatment of post-thrombotic syndrome
BTG has highlighted the results of the ACCESS PTS trial, presented at the Society for Vascular Medicine 28th annual scientific sessions (14–17 June, New...
Twelve-month NEAT trial data promising for everlinQ endoAVF haemodialysis access system
TVA Medical has announced the online publication of positive results from the Novel Endovascular Access Trial (NEAT) evaluating its everlinQ endoAVF system. The 12-month...
Inauguration of the first Infinix-i 4D CT in Europe
The Montpellier University Hospital (Montpellier, France) has inaugurated an avant-garde interventional radiology intervention room in the Department of Interventional Radiology at the St-Eloi Hospital....
Study suggests uterine fibroid embolization helps restore fertility
The treatment can help restore fertility in women with uterine fibroids, according to a new study published online in the journal Radiology.
Uterine fibroids are...
SIO announces first grants in interventional oncology /immuno-oncology research programme
The Society of Interventional Oncology (SIO and BTG have announced their 2017 Interventional interventional oncology /immuno-oncology research grant recipients.
The interventional oncology /immuno-oncology research programme...
IN.PACT Admiral approved for reimbursement in France and Belgium
Medtronic has announced recent reimbursement approvals in both France and Belgium.
A Ministerial decree was published in the Official Journal of French Republic to enlist...
Pioneer Plus catheter re-entry device with intravascular ultrasound guidance relaunched
Philips has announced the relaunch of the Pioneer Plus catheter, described as the only re-entry device with intravascular ultrasound (IVUS) capabilities and needle deployment...
SIRveNIB abstract published by ASCO, to be presented on 4 June
SIRveNIB is an investigator-led Asia Pacific Primary Liver Cancer Study to be presented on 4 June 2017 at the American Society of Clinical Oncology...
Adept Medical launches I.R Platform
Adept Medical, the Auckland based manufacturer of the STARSystem, has announced the release of its latest product innovation, the I.R. Platform (interventional radiology platform)....
First patient enrolled in IN.PACT arteriovenous access drug-coated balloon study
The US FDA has approved the investigational device exemption (IDE) study to evaluate the safety and efficacy of IN.PACT AV access drug-coated balloon as...
REsect study shows SIRT makes metastatic colorectal cancer patients more likely...
Metastatic colorectal cancer patients treated first-line with SIR-spheres Y-90 resin microspheres more likely to become candidates for potentially curative liver surgery, the REsect study...
New data show SIRT does not prolong overall survival in metastatic...
The FOXFIRE, SIRFLOX and FOXFIRE Global randomised studies evaluated the efficacy of combining first-line chemotherapy for metastatic colorectal cancer with selective internal radiotherapy (SIRT)...
Medtronic gets option to purchase QT Vascular’s non-drug coated Chocolate PTA
QT Vascular has announced that it has entered into an asset purchase option agreement with Medtronic, for the acquisition of the non-drug coated Chocolate...
High radiation dose to operator with prostatic artery embolization, until imaging...
According to our results, the physician who performs prostatic artery embolization procedures, even with a ceiling suspended shield, would reach the annual radiation limit...
Interrupting inflammatory signals decreases repeat artery blockage in peripheral arterial disease...
Peripheral artery disease patients who were treated with an anti-inflammatory steroid injected directly into the tissue surrounding their leg artery showed a significant reduction...
CIRA appoints Daniel Lapointe as new executive director
The Canadian Interventional Radiology Association (CIRA) Board of Directors has announced the appointment of Daniel Lapointe as CIRA’s new executive director on the association’s...
German Federal Institute for Drugs and Medical Devices approves new indication...
Guerbet has announced that the Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM; The German Federal Institute for Drugs and Medical Devices) has now approved Lipiodol...
Consistent results for Medtronic IN.PACT Admiral in complex peripheral artery disease...
Two new sub-analyses from the IN.PACT Global Study of the IN.PACT Admiral in patients with peripheral artery disease have been reported at the annual...
Positive results for Boston Scientific Ranger paclitaxel-coated PTA balloon catheter
Positive results from the RANGER SFA trial for Boston Scientific’s Ranger paclitaxel-coated percutaneous transluminal angioplasty (PTA) balloon catheter have been presented at the 2017...
BD to acquire Bard for US$24 billion
BD (Becton, Dickinson and company) has definitively agreed to acquire Bard for US$317 per common share in cash and stock, for a total consideration...
SIRT significantly better tolerated than sorafenib, but does not increase overall...
The 459-patient randomised controlled SARAH study shows that local treatments of advanced or inoperable hepatocellular carcinoma with selective internal radiation therapy (SIRT) did not...
Getinge launches the new Advanta V12 32mm balloon expandable covered stent
Getinge is proud to announce the launch of the Advanta V12 32mm length balloon expandable covered stent at the Charing Cross International Conference. This...
First European patients treated with DC Bead Lumi radiopaque drug-eluting beads
Two patients were treated for hepatocellular carcinoma and one patient was treated for malignant colorectal cancer metastasised to the liver.
DC Bead Lumi is...
PAIRS meeting showcases interventional radiology trends in the Middle East
The 2017 edition of the annual PAIRS meeting was held in Dubai 15–18 March and reflected the growing enthusiasm of the interventional radiology community...
Merit showcases new generation radial compression device
Merit has showcased a new radial compression product, Preludesync, on its website.
The Preludesync devices assists in achieving vascular haemostasis. It features a large area...
Medical Groups unite in support of science in the USA
The Society of Interventional Radiology (SIR), the American Society of Hematology and 23 other medical societies have released a statement in support of the...
Women with fibroids see significant improvement in sexual function one year...
A study published online ahead of print in CardioVascular and Interventional Radiology (CVIR) has demonstrated that at one year, uterine fibroid embolization significantly improves...
Identification of pancreatic cancer pathway could broach new era of effective...
Pancreatic Cancer Action Network (PanCAN) grantee George Miller, head of the Cancer Immunology Program at Perlmutter and vice chair for research in the Department...
First US patient treated in vascular study of Lithoplasty technology
PinnacleHealth CardioVascular Institute has enrolled the first US patient in a trial assessing the safety and effectiveness of a new type of approach for...
Codman Neuro acquires Neuravi
Codman Neuro has announced the acquisition of Neuravi. This acquisition comes after the company’s recent acquisition of Pulsar Vascular, expanding its products for stroke...
Ivolution now available in 200mm length devices
Ivascular has announced the product range extension of its self-expandable stent, iVolution, to 200mm length, in various diameters.
Ivolution is a nitinol endovascular stent, combining...
UK Medical announces ‘strategic buy out’ from BD
A Sheffield healthcare company has announced a strategic ‘buy out’ from its parent company, BD (Becton, Dickinson and Company), a deal which will see...
Terumo announces first commercial clinical case using Quiremspheres
Terumo Europe NV has announced the first commercial clinical case using Quiremspheres—the next generation radioembolization microspheres for advanced unresectable liver cancer.
Quiremspheres are the only...
Study suggests adenomatous-dominant benign prostatic hyperplasia could predict successful embolization
A study recently published in Cardiovascular and Interventional Radiology has, for the first time, identified adenomatous-dominant benign prostatic hyperplasia as a predictor of clinical...
Cryoablation allows safe and effective local control of breast cancer
“Cryoablation of metastatic breast cancer is a safe and effective method that allows local control of the disease,” Claudio Pusceddu told delegates at the...
Hitting cancer with high-intensity ultrasound and immunotherapy
In a new study published in JCI Insight, UC Davis researchers have shown that combining high-intensity focused ultrasound with two immunotherapies (a PD-1 checkpoint...
Solero microwave ablation system gets CE mark
Angiodynamics has announced it has received CE mark certification for the Solero microwave tissue ablation system. Solero and its accessories are indicated for the...
Mirabilis announces European approval for non-invasive uterine fibroid treatment
Mirabilis has announced CE mark authorisation to market the Mirabilis System in the European Union. The system combines high-speed therapeutic ultrasound technology with an...
Metactive announces issuance of patents on Blockstent and Ballstent embolization devices
Metactive, an early-stage company focused on developing embolization devices for the treatment of peripheral vascular and neurovascular diseases, has announced the issuance of US...
New meta-analysis supports RenalGuard use in cardiovascular interventional procedures
The new meta-analysis, presented as a poster by researchers from the University of Texas Health Sciences Center, San Antonio, USA, during the 2017 American...
Siemens Healthineers introduces innovations in ultrasound guidance and liver embolization
The new Acuson Freestyle Elite ultrasound system can now be combined with the Artis angiography systems to enable fast and easy-to-use ultrasound guidance during...
Randomised trial finds no difference in changes between MS patients who...
Venoplasty is not effective in treating multiple sclerosis, according to the first presentation of interim data from a randomised, double blind clinical trial of...
Artificial intelligence virtual consultant could guide interventional radiology patient care
Interventional radiologists at the University of California at Los Angeles (UCLA), Los Angeles, USA, are using technology found in self-driving cars to power a...
1,000-patient study indicates prostate artery embolization remains effective for years
Prostate artery embolization maintains its effectiveness for at least three years after patients undergo the therapy, according to research presented at the Society of...
Bluegrass Vascular announces strategic relationship with Merit Medical
Bluegrass Vascular has announced that it is entering into a strategic relationship with Merit Medical. The agreement will streamline European distribution of the recently...
ATTRACT fails to meet primary endpoint, but experts agree results are...
Data from the randomised controlled ATTRACT trial revealed that the addition of catheter-based intervention to standard-of-care anticoagulation failed to significantly decrease the occurrence of...
US study suggests fibroid embolization “vastly underutilised” compared with hysterectomy
A large US nationwide study shows that the uterine fibroid embolization is vastly underutilised, compared to hysterectomy—especially in rural and smaller hospitals.
In fact, there...
Innovative catheter-based treatment offers relief to children with frequent migraines
A minimally invasive treatment for migraine headaches used for adults is also proving to be a safe and effective treatment for children and teenagers....
Interventional oncology should identify “unmet immunotherapy needs”
Daniel Sze, speaking at the ninth annual Symposium on Clinical Interventional Oncology (CIO; 4–5 February 2017, Hollywood, USA), noted that immunotherapy is a “huge...
Thailand FDA approves new indication for Guerbet’s Lipiodol Ultra-Fluide
Guerbet has announced that the Thailand FDA has given approval of a new indication for Lipiodol Ultra-Fluide for selective hepatic intra-arterial injection for visualisation,...
Surefire closes US$12.8 million funding, to present new data at SIR
Surefire, the developer of site-specific delivery devices for the interventional oncology market, has announced the first closing of a US$12.8 M Series D financing...
Mentice releases world’s first endovascular simulation training software module for prostatic...
Mentice has announced the release of the world’s first simulation training software module for prostatic artery embolization. The software, created from real patients’ data,...
Gregory John Slater
"War (as in turf war) is an emotional word because, in wars, people get hurt. I believe we truly care about the patients we...
ATTRACT trial results to be presented at SIR 2017 meeting
Suresh Vedantham, professor of Radiology and Surgery, Mallinckrodt Institute of Radiology, Washington University School of Medicine in St Louis, USA, is scheduled to present the...
BTG receives US FDA 510(k) clearance for Ekos control unit 4.0
BTG has announced that US FDA 510(k) clearance has been granted to the Ekos control unit 4.0.
The Ekos system includes an ultrasonic device...
Cook Medical announces Universa sets to streamline percutaneous drainage product line
Cook Medical has rounded out the Universa line with the introduction of two new sets for percutaneous urinary drainage.
Each set includes a catheter and...
ASTER results support use of Penumbra aspiration as frontline thrombectomy therapy...
Penumbra has announced the presentation of the results of the ASTER trial, the first independent, prospective, randomised trial comparing the use of Penumbra’s aspiration...
Philips launches Azurion worldwide
Philips has announced the global launch of Azurion, its next generation image-guided therapy platform, which forms the new core of its integrated solutions portfolio...
Adding interventional oncology to immuno-oncology
Some research data suggest there could be a synergistic effect between immunotherapy and minimally invasive procedures. Tumour types that do not respond to checkpoint...
BTG and SIO to explore role of minimally invasive therapies in...
BTG has announced a collaboration with the Society of Interventional Oncology (SIO; a global organisation working to nurture and support interventional oncology worldwide) to...
OsteoCool RF ablation system gets expanded indication for palliative treatment of...
Medtronic has announced that the US FDA has cleared an expanded indication for the OsteoCool radiofrequency (RF) ablation system.
Originally cleared for use in the...
Barry Katzen announces new global society for critical limb ischaemia
Barry Katzen, Miami, USA, announced the establishment of a new society, the Critical Limb Ischaemia (CLI) Global Society, whose mission is to improve quality...
DANCE data boost for dexamethasone use after revascularisation in femoropopliteal arteries
While drug-eluting devices, be they balloons or stents, use chemotherapeutic agents (usually paclitaxel) to reduce the build-up of scar tissue inside the arteries, a...
Argon sells critical care platform to Merit
Argon has announced that it has completed the sale of its Critical Care Unit including a manufacturing facility in Yishun, Singapore and related commercial...
Society of Interventional Radiology statement on US president Donald J Trump’s...
Society of Interventional Radiology (SIR) president Charles E Ray Jr has issued the following statement in response to US president Donald J Trump’s executive...
Tom Daschle to address future of healthcare at special SIR 2017...
Former US Senate majority leader Tom Daschle will headline a special 9 March symposium "IR Economics, Quality and Value: Are You Ready For MACRA?"...
Guerbet expands distribution partnership in Canada with Methapharm
Guerbet has announced that as of 1 February 2017, Methapharm will promote and distribute all Guerbet products in Canada.
"As a result of our excellent...
US FDA approves first balloon expandable stent graft to treat iliac...
Gore has announced that the Gore Viabahn VBX balloon expandable endoprosthesis has received US FDA approval for treatment of de novo or restenotic lesions...
MAVERRIC to compare microwave ablation to surgery for resectable colorectal liver...
The Karolinska Institute-sponsored, prospective, observational MAVERRIC study aims to demonstrate that a strategy of first line local microwave ablation of colorectal liver metastases is...
SARAH study results to be presented as oral abstract at April...
Sirtex has announced that the SARAH (Sorafenib vs. radioembolisation in advanced hepatocellular carcinoma) randomised controlled study results will be presented at the upcoming European...
TVA Medical presents positive everlinQ endoAVF system results at LINC 2017
TVA Medical has provided clinical updates involving its everlinQ endoAVF system at the 2017 Leipzig Interventional Course (LINC; 24–17 January, Leipzig, Germany).
Scientific data were...
Terumo completes acquisition of vascular closure business and other assets of...
Terumo has announced that it has completed its acquisition of certain assets owned by Abbott and St Jude Medical on 20 January 2017 (North...
Lymphatic embolization leads to successful treatment of plastic bronchitis in adults
Researchers who developed a safe and effective procedure to remove thick clogs in children's airways are now reporting similar success in adult patients. In...
Terumo sets sight on Bolton to accelerate growth of vascular graft...
Terumo Corporation has announced that it has entered into a definitive agreement under which it has agreed to acquire Bolton Medical from its parent...
WCIO establishes Society of Interventional Oncology
WCIO has announced via email communication that the board of directors of the organisation, a non-profit association that supports and promotes the field of...
Ulipristal acetate first oral therapy to show positive phase III results...
Ulipristal acetate is the first oral therapy to demonstrate efficacy and safety for uterine fibroids in two US pivotal studies, a press release states.
Allergan...
The ESR and CIRSE join forces to promote patient care
The European Society of Radiology (ESR) and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE), have joined forces to address the future of...
First pulmonary embolism patients in Hong Kong treated with the BTG’s...
The first Hong Kong-based patients diagnosed with pulmonary embolism have been treated using the newly available BTG EKOS system. The EKOS system includes an...
Ask4UFE launches #LoveYourUterus campaign
Ask4UFE has announced the #LoveYourUterus campaign to encourage women with painful fibroids to share their stories of health and healing. Uterine fibroids often result...
Teleflex gets US FDA nod for Arrow VPS Rhythm with optional...
Teleflex has announced that its Arrow VPS Rhythm device with optional TipTracker technology has been issued 510(k) clearance so that the device can be...
Abbott completes St Jude Medical acquisition
Abbott announced on 4 January 2017 that it has completed the acquisition of St Jude Medical.
“Abbott has a strong track record of successfully integrating...
Canada first country to get DC Bead Lumi treatment for liver...
BTG International Canada has announced the commercial launch of DC Bead Lumi in Canada. The launch represents the first market commercialisation of DC Bead...
New NCCN guidelines recommend SIRT for the treatment of metastatic colorectal...
Sirtex has announced that SIR-Spheres Y-90 resin microspheres have been included as a Category 2A recommended treatment in the latest National Comprehensive Cancer Network...
ConvertX nephroureteral stent system gets US FDA clearance
BrightWater Medical has announced that the US FDA has cleared the company’s innovative ConvertX nephroureteral stent system for treatment of ureteral obstructions.
Patients with...
TEVAR’s dirty little secret
“There is no easy fix with current endovascular tools and strategies and a default realisation is that it is easier and more definitive to...
SIRT access “under threat” from commissioning through evaluation process
Selective internal radiation therapy (SIRT) has been available since December 2013 to a defined group of patients with liver metastases in England on the...
Spectranetics gets CE mark for Stellarex 0.014” drug-coated balloon
Spectranetics has announced that its Stellarex 0.014” drug-coated angioplasty balloon has received the CE mark. The device is designed to treat small vessels, below-the...
Final patient enrolled for VIVO iliofemoral venous stent study
Cook Medical has completed enrolment in the first clinical study of an iliofemoral venous stent conducted in the USA under a US FDA-approved investigational device exemption.
The...
Merit Medical receives 510(k) clearance for the SwiftNinja steerable microcatheter
Merit Medical Systems has received 510(k) clearance for the SwiftNinja steerable microcatheter, covering peripheral and coronary applications.
With the exception of Japan, Merit has global...
Early data suggest ablation has favourable outcomes for selected small cell...
A preliminary analysis suggests that thermal ablation may be effective in selected patients with local small cell lung cancer without adjuvant therapy. The research...
Twelve-month PARADIGM study data demonstrate benefit of CGuard Embolic Prevention System...
InspireMD has announced 12-month follow up data from PARADIGM-101 study of the CGuard Embolic Prevention System (EPS), which were presented at the Transcatheter Cardiovascular...
Shockwave Medical announces plans for “largest ever” calcified peripheral artery disease...
Shockwave Medical has announced plans for DISRUPT PAD III—what it claims is the “largest ever” multicentre randomised study to exclusively enrol patients with calcified...
US FDA approves TOBA II BTK pivotal IDE clinical study
The US Food and Drug Administration (FDA) has granted staged approval for Intact Vascular’s investigational device exemption (IDE) application to begin its TOBA II...
St Jude Medical shareholders approve merger with Abbott
St Jude Medical has announced that, based on the preliminary voting results from St Jude Medical’s Annual Meeting of Shareholders held on 26 October,...
Medtronic gets FDA clearance of new lower profile HawkOne 6F directional...
Medtronic has received US FDA 510(k) clearance for the HawkOne directional atherectomy system in a new size for treating patients with peripheral artery disease....
Irreversible electroporation has “potential to become new standard of care” in...
A new study presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE 2016, 10–14 September, Barcelona, Spain) meeting finds that the treatment...
3D printing customised vascular stents could minimise complications
Most people have heard about personalised medicine. How about personalised medical devices? Northwestern’s McCormick School of Engineering researchers Guillermo Ameer and Cheng Sun have...
Terumo looks to buy vascular closure and electrophysiology businesses from St...
Abbott and St Jude Medical have announced an agreement in principle to sell certain products to Terumo Corporation.The agreement is an important step toward...
SARAH and SIRveNIB investigators to undertake combined prospective meta-analysis
Liver cancer researchers from France and Singapore collaborate on a prospective meta-analysis of two studies of Y-90 resin microspheres vs. sorafenib in patients with...
BTG and Mirada Medical announce CE mark certification for Simplicit90Y dosimetry...
BTG and Mirada Medical announced CE mark certification for the Simplicit90Y dosimetry software, designed to optimise the planning of Y-90 selective internal radiation therapy...
Percutaneously created arteriovenous fistulae need far fewer post-creation interventions than those...
NEAT (Novel endovascular access trial) data presented at the Vascular Interventional Advances (VIVA) 2016 meeting (18–22 September, Las Vegas, USA) suggest that endovascular arteriovenous...
CORAL data point to large patient group who might benefit from...
Timothy P Murphy, Vascular Disease Research Center, Rhode Island Hospital, Providence, USA, and one of the investigators on the CORAL study, told delegates at...
New ESMO biliary cancer guidelines indicate radioembolization as an option for...
New European Society of Medical Oncology (ESMO) biliary cancer guidelines indicate yttrium-90 (Y-90) therapy as an option for post-chemotherapy treatment of intrahepatic cholangiocarcinoma.
Sirtex has announced...
Teleflex receives US FDA clearance for Arrow and TightTrack tunneler
Teleflex has announced that it has received US FDA 510(k) clearance to market its Arrow JACC with Chlorag+ard technology and TightTrack tunneler.
Arrow JACC...
First US commercial placements of Angel catheter
Bio2 Medical has announced that the Angel catheter, a new device for the prevention of pulmonary embolism, was placed in two patients at St...
Lumee Oxygen Platform for continuous, real-time monitoring of tissue oxygen receives...
Profusa has announced that receiving the CE mark to market its Lumee Oxygen Platform for continuous, real-time monitoring of tissue oxygen.
The company will initially...
Ra Medical receives approval in Europe for Dabra atherectomy system
Ra Medical has announced receiving CE mark approval for the Dabra atherectomy system with catheter.
Atherectomy is the removal of the plaque from the arteries,...
Medtronic receives US FDA clearance for TrailBlazer angled peripheral support catheter
Medtronic has announced that the US FDA has cleared the TrailBlazer angled support catheter for use in the peripheral vascular system. Support catheters such...
SOLSTICE preliminary data show cryoablation has “acceptable safety profile” in treatment...
The SOLSTICE clinical study constitutes the largest multicentre, prospective study focused on the clinical use and effectiveness of cryotherapies for patients with primary cancer...
Lutonix Global Real-World Registry 24-month outcomes presented at VIVA 2016
Bard has announced the presentation of the final 24-month results from the Lutonix Global Real-World Registry at the Vascular Intervention Advances (VIVA) 2016 meeting...
Majority of patients treated with embolization for symptomatic fibroids can avoid...
Ten-year outcomes from the randomised controlled EMMY trial were presented at CIRSE 2016 (10–14 September, Barcelona, Spain) by Jim Reekers, Academic Medical Center, Amsterdam,...
Two-year MAJESTIC data show sustained positive results for Eluvia drug-eluting stent
The MAJESTIC trial set out to evaluate the performance of the Eluvia paclitaxel-eluting vascular stent system (Boston Scientific) in the treatment of femoropopliteal artery...
Shockwave announces positive six-month DISRUPT PAD results in patients with calcified...
Shockwave Medical has announced positive clinical results from the pooled DISRUPT PAD study, a single-arm, two-phase, multicentre study evaluating the safety and performance of...
Three-year IN.PACT SFA trial results demonstrate durability, safety and efficacy for...
Medtronic reinforced the durability, consistency, and safety of the IN.PACT Admiral drug-coated balloon in patients with peripheral arterial disease with new data presented in a...
First implant placed in Gore Tag thoracic branch endoprosthesis pivotal study
Gore has announced the placement of the first implant of the Gore Tag thoracic branch endoprosthesis in the pivotal study. The patient was enrolled...
Shockwave Medical Lithoplasty system cleared by the US FDA
Shockwave Medical has announced clearance from the US FDA of the Lithoplasty system for the treatment of calcified plaque in patients with peripheral arterial...
SIRT Users’ Network announces European expansion
The SIRT Users' Network of professionals who treat liver cancer is to extend across the UK, Belgium, Spain and Italy
The success of the SIRT Users' Network,...
Philips introduces next generation interventional oncology solution for advanced tumour analysis...
Royal Philips has announced the unveiling of its latest innovation in interventional oncology at the Cardiovascular and Interventional Radiological Society of Europe annual meeting...
CIRSE 2016: Following the beat of modern interventions
See you in Barcelona, September 10-14, for CIRSE 2016 – the world’s largest interventional radiology congress. ...
Gore DrySeal Flex introducer sheath now commercially available
Gore has announced the commercial availability of the Gore DrySeal Flex introducer sheath, after recently gaining clearance for use by regulatory bodies in the...
Bluegrass Vascular gets CE mark approval for Surfacer Inside-Out access catheter...
Bluegrass Vascular has announced receiving CE mark approval for the Surfacer Inside-Out access catheter system, indicated for obtaining central venous access to facilitate catheter...
Revascularisation beats medical management in treatment of intermittent leg claudication
A new study, based on patient-reported outcomes, published online ahead of print on 17 August in JAMA Surgery reports that patients with intermittent claudication...
One-year results of the ILLUMENATE trial show positive results for Stellarex...
Marianne Brodmann, Medical University Graz, Austria, presented the final 12-month results of the ILLUMENATE European randomised clinical trial at the Amputation Prevention Symposium in...
Biopsy after ablation of colorectal metastases “feasible” to identify local progression
Incomplete tumour treatment and local tumour progression remain important limitations to the widespread use of radiofrequency ablation for colorectal liver metastases. This means it...
New documentary titled “Without a Scalpel” to be distributed via video...
The Interventional Initiative, Oakland, USA and Evolve Media Production, San Francisco and New York, USA, have announced the distribution of episode one of the...
BTG announces successful CE mark reclassification for DC Bead to class...
BTG has announced that it has obtained CE mark from the Notified Body British Standards Institution (BSI) following completion of the reclassification of DC...
Substantial growth in ordering of CTA exams in Medicare population
According to a new study by the Harvey L. Neiman Health Policy Institute, the last 13 years have seen a substantial growth in the...
Promising findings for novel drug-eluting peripheral stent
A new animal study, presented at EuroPCR (17–20 May, Paris), indicates that a novel, fluoropolymer-coated, self-expanding, paclitaxel-eluting peripheral stent (Eluvia, Boston Scientific) is associated...
Positioning microwave antenna at least 5mm from heart may reduce cardiac...
Speaking at the World Conference on Interventional Oncology (WCIO; 9–12 June, Boston, USA), George Carberry (University of Wisconsin School of Medicine and Public Health,...
Contego Medical completes enrolment of Paladin clinical registry
Contego Medical has completed enrolment in the Paladin Carotid Post-dilation Balloon System Registry in Europe. The registry involves five centres with 100 patients, and...
AV Medical announces initial US experience with Chameleon angioplasty balloon catheter
AV Medical has announced the commencement of cases in the US with its Chameleon percutaneous transluminal angioplasty balloon catheter.
With its Supervision design, Chameleon...
Medtronic gets FDA nod for longer, 150mm length, IN.PACT Admiral drug-coated...
Medtronic has received US FDA approval for the IN.PACT Admiral drug-coated balloon in longer, 150mm, lengths. The new 150mm length balloon, available in four,...
Varithena gets US FDA approval for 30 day post-activation shelf life
BTG has announced that the US FDA has approved an extension of the post-activation shelf life of Varithena (polidocanol injectable foam) 1% to thirty...
European launch of Altura expanded
Lombard Medical has announced that it has expanded the European launch of its new Altura endovascular stent graft system to The Netherlands and Spain....
Major amputation over utilised globally for critical limb ischaemia
Due to an absence of standardised protocols, major amputation is being over utilised worldwide as a treatment for critical limb ischaemia, according to Mary Yost,...
Two year RENOVA randomised data provide boost for stent graft use...
The results from a prospective, randomised study, published online ahead of print in the Journal of Vascular and Interventional Radiology (JVIR) suggest that stent...
Merit Medical pays US$97.5 million to acquire Dfine
Dfine’s products are directed to vertebral augmentation (kyphoplasty and vertebroplasty), as well as targeted radiofrequency ablation of metastatic spinal tumours and these product lines...
SRS Medical gets CE mark approval for Spanner prostate stent
SRS Medical Systems has announced that it has received CE mark approval for use of its Spanner temporary prostate stent in the European Economic...
